Gf Fund Management Co. Ltd. Vir Biotechnology, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,526 shares of VIR stock, worth $21,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,526
Previous 2,892
21.92%
Holding current value
$21,579
Previous $21.2 Million
7.64%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
234Shares Held
90MCall Options Held
1.28MPut Options Held
235K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$102 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$80.4 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$31.1 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$19.7 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $812M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...